These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27647374)

  • 1. Human 15-LOX-1 active site mutations alter inhibitor binding and decrease potency.
    Armstrong M; van Hoorebeke C; Horn T; Deschamps J; Freedman JC; Kalyanaraman C; Jacobson MP; Holman T
    Bioorg Med Chem; 2016 Nov; 24(21):5380-5387. PubMed ID: 27647374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic and structural investigations of novel inhibitors of human epithelial 15-lipoxygenase-2.
    Tsai WC; Gilbert NC; Ohler A; Armstrong M; Perry S; Kalyanaraman C; Yasgar A; Rai G; Simeonov A; Jadhav A; Standley M; Lee HW; Crews P; Iavarone AT; Jacobson MP; Neau DB; Offenbacher AR; Newcomer M; Holman TR
    Bioorg Med Chem; 2021 Sep; 46():116349. PubMed ID: 34500187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potent and selective inhibitor targeting human and murine 12/15-LOX.
    Armstrong MM; Freedman CJ; Jung JE; Zheng Y; Kalyanaraman C; Jacobson MP; Simeonov A; Maloney DJ; van Leyen K; Jadhav A; Holman TR
    Bioorg Med Chem; 2016 Mar; 24(6):1183-90. PubMed ID: 26899595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of 6-benzyloxysalicylates as a novel class of inhibitors of 15-lipoxygenase-1.
    Eleftheriadis N; Thee S; te Biesebeek J; van der Wouden P; Baas BJ; Dekker FJ
    Eur J Med Chem; 2015 Apr; 94():265-75. PubMed ID: 25771032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docking and mutagenesis studies lead to improved inhibitor development of ML355 for human platelet 12-lipoxygenase.
    Tsai WC; Aleem AM; Tena J; Rivera-Velazquez M; Brah HS; Tripathi S; D'silva M; Nadler JL; Kalyanaraman C; Jacobson MP; Holman T
    Bioorg Med Chem; 2021 Sep; 46():116347. PubMed ID: 34507163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, biological evaluation and docking studies of new 3-(4,5-dihydro-1H-pyrazol/isoxazol-5-yl)-2-phenyl-1H-indole derivatives as potent antioxidants and 15-lipoxygenase inhibitors.
    ElBordiny HS; El-Miligy MM; Kassab SE; Daabees H; Mohamed Ali WA; Abdelhamid Mohamed El-Hawash S
    Eur J Med Chem; 2018 Feb; 145():594-605. PubMed ID: 29339254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high throughput screen identifies potent and selective inhibitors to human epithelial 15-lipoxygenase-2.
    Jameson JB; Kantz A; Schultz L; Kalyanaraman C; Jacobson MP; Maloney DJ; Jadhav A; Simeonov A; Holman TR
    PLoS One; 2014; 9(8):e104094. PubMed ID: 25111178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for altered positional specificity of 15-lipoxygenase-1 with 5S-HETE and 7S-HDHA and the implications for the biosynthesis of resolvin E4.
    Perry SC; van Hoorebeke C; Sorrentino J; Bautista L; Akinkugbe O; Conrad WS; Rutz N; Holman TR
    Arch Biochem Biophys; 2022 Sep; 727():109317. PubMed ID: 35709965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of NSAIDs as lipoxygenase inhibitors through highly sensitive chemiluminescence method, expression analysis in mononuclear cells and computational studies.
    Shahid W; Ejaz SA; Al-Rashida M; Saleem M; Ahmed M; Rahman J; Riaz N; Ashraf M
    Bioorg Chem; 2021 May; 110():104818. PubMed ID: 33784531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of 12/15-Lipoxygenase Protects Against β-Cell Oxidative Stress and Glycemic Deterioration in Mouse Models of Type 1 Diabetes.
    Hernandez-Perez M; Chopra G; Fine J; Conteh AM; Anderson RM; Linnemann AK; Benjamin C; Nelson JB; Benninger KS; Nadler JL; Maloney DJ; Tersey SA; Mirmira RG
    Diabetes; 2017 Nov; 66(11):2875-2887. PubMed ID: 28842399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-prenylated 3-carboxycoumarins as a novel class of 15-LOX-1 inhibitors.
    Jabbari A; Mousavian M; Seyedi SM; Bakavoli M; Sadeghian H
    PLoS One; 2017; 12(2):e0171789. PubMed ID: 28182779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory and mechanistic investigations of oxo-lipids with human lipoxygenase isozymes.
    Armstrong MM; Diaz G; Kenyon V; Holman TR
    Bioorg Med Chem; 2014 Aug; 22(15):4293-7. PubMed ID: 24924423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent and selective inhibitors of human reticulocyte 12/15-lipoxygenase as anti-stroke therapies.
    Rai G; Joshi N; Jung JE; Liu Y; Schultz L; Yasgar A; Perry S; Diaz G; Zhang Q; Kenyon V; Jadhav A; Simeonov A; Lo EH; van Leyen K; Maloney DJ; Holman TR
    J Med Chem; 2014 May; 57(10):4035-48. PubMed ID: 24684213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of 15-lipoxygenase inhibitors in cancer treatment.
    Orafaie A; Matin MM; Sadeghian H
    Cancer Metastasis Rev; 2018 Sep; 37(2-3):397-408. PubMed ID: 29882120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity-Based Probes for 15-Lipoxygenase-1.
    Eleftheriadis N; Thee SA; Zwinderman MR; Leus NG; Dekker FJ
    Angew Chem Int Ed Engl; 2016 Sep; 55(40):12300-5. PubMed ID: 27612308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of 5-benzylidenerhodanine-3-acetic acid derivatives as AChE and 15-LOX inhibitors.
    Shafii N; Khoobi M; Amini M; Sakhteman A; Nadri H; Moradi A; Emami S; Saeedian Moghadam E; Foroumadi A; Shafiee A
    J Enzyme Inhib Med Chem; 2015 Jun; 30(3):389-95. PubMed ID: 26095345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of natural 15-LOX small molecule inhibitors from Chinese herbal medicine using virtual Screening, biological evaluation and molecular dynamics studies.
    Li Y; Zhang Y; Wu X; Gao Y; Guo J; Tian Y; Lin Z; Wang X
    Bioorg Chem; 2021 Oct; 115():105197. PubMed ID: 34426159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of lipoxygenase specificity by targeted substrate modification and site-directed mutagenesis.
    Walther M; Ivanov I; Myagkova G; Kuhn H
    Chem Biol; 2001 Aug; 8(8):779-90. PubMed ID: 11514227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
    Rao PN; Chen QH; Knaus EE
    J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active site characterization and structure based 3D-QSAR studies on non-redox type 5-lipoxygenase inhibitors.
    Ul-Haq Z; Khan N; Zafar SK; Moin ST
    Eur J Pharm Sci; 2016 Jun; 88():26-36. PubMed ID: 27044904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.